PHARMACYTE BIOTECH, INC. Accounts Payable
PHARMACYTE BIOTECH, INC. (PMCB) had Accounts Payable of $390.54 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-09-14
- 2026-07-31: Accounts Payable, Current $390.54K.
- 2026-04-30: Accounts Payable, Current $271.10K.
- 2026-01-31: Accounts Payable, Current $1.20M.
- 2025-10-31: Accounts Payable, Current $1.02M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-07-31 | $390.54K 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $271.10K 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $1.20M 10-Q · filed 2026-03-17 | |
| 2025-10-31 | $1.02M 10-Q · filed 2025-12-18 | |
| 2025-07-31 | $465.21K 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $399.20K 10-K · filed 2026-07-29 | |
| 2025-01-31 | $484.95K 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $348.60K 10-Q · filed 2024-12-13 | |
| 2024-07-31 | $553.95K 10-Q · filed 2024-09-17 | |
| 2024-04-30 | $389.37K 10-K · filed 2025-08-11 | |
| 2024-01-31 | $484.20K 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $126.16K 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $718.13K 10-Q · filed 2023-09-18 | |
| 2023-04-30 | $128.28K 10-K · filed 2024-08-13 | |
| 2023-01-31 | $445.94K 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $861.28K 10-Q · filed 2022-12-14 | |
| 2022-07-31 | $559.03K 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $205.36K 10-K · filed 2023-07-31 | |
| 2022-01-31 | $92.86K 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $157.04K 10-Q · filed 2021-12-14 | |
| 2021-07-31 | $394.77K 10-Q · filed 2021-09-14 | |
| 2021-04-30 | $172.26K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $79.16K 10-Q · filed 2021-03-12 | |
| 2020-10-31 | $80.12K 10-Q · filed 2020-12-11 | |
| 2020-07-31 | $384.83K 10-Q · filed 2020-09-11 | |
| 2020-04-30 | $185.84K 10-K · filed 2021-08-10 | |
| 2020-01-31 | $340.49K 10-Q · filed 2020-03-13 | |
| 2019-10-31 | $164.58K 10-Q · filed 2019-12-23 | |
| 2019-07-31 | $67.55K 10-Q · filed 2019-09-13 | |
| 2019-04-30 | $121.89K 10-K · filed 2020-08-13 | |
| 2019-01-31 | $133.68K 10-Q · filed 2019-03-14 | |
| 2018-10-31 | $348.64K 10-Q · filed 2018-12-14 | |
| 2018-07-31 | $575.01K 10-Q · filed 2018-09-12 | |
| 2018-04-30 | $352.62K 10-K · filed 2019-08-13 | |
| 2018-01-31 | $305.59K 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $310.81K 10-Q · filed 2017-12-14 | |
| 2017-07-31 | $628.18K 10-Q · filed 2017-09-13 | |
| 2017-04-30 | $365.60K 10-K · filed 2018-07-20 | |
| 2017-01-31 | $435.00K 10-Q · filed 2017-03-13 | |
| 2016-10-31 | $300.90K 10-Q · filed 2016-12-02 | |
| 2016-07-31 | $311.63K 10-Q · filed 2016-09-06 | |
| 2016-04-30 | $336.01K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $697.32K 10-Q · filed 2016-03-08 | |
| 2015-10-31 | $427.21K 10-Q/A · filed 2016-01-19 | |
| 2015-07-31 | $413.12K 10-Q/A · filed 2016-01-19 | $413.12K 10-Q · filed 2015-08-25 |
| 2015-04-30 | $496.70K 10-K · filed 2016-07-29 | |
| 2015-01-31 | $375.79K 10-Q · filed 2015-03-13 | |
| 2014-10-31 | $272.11K 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $204.37K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $188.04K 10-K/A · filed 2016-01-19 | |
| 2014-01-31 | $167.68K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $285.73K 10-Q · filed 2013-12-16 | |
| 2013-07-31 | $295.57K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $352.00K 10-K · filed 2014-08-04 | |
| 2013-01-31 | $517.39K 10-Q · filed 2013-03-26 | |
| 2012-10-31 | $463.66K 10-Q · filed 2012-12-26 | |
| 2012-07-31 | $424.18K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $730.07K 10-K · filed 2013-07-29 | |
| 2012-01-31 | $572.26K 10-Q · filed 2012-03-21 | |
| 2011-10-31 | $702.98K 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $692.55K 10-Q/A · filed 2011-09-20 | |
| 2011-04-30 | $705.76K 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |